Mitochondrial Mutations in Atherosclerosis: New Solutions in Research and Possible Clinical Applications

By  

Current Pharmaceutical Design, Vol. 19, Iss. 33, 2013-10 ,pp. : 5942-5953

Bentham Science Publishers

Access to resources Recommend Favorite

Role and Treatment of Mitochondrial DNA-Related Mitochondrial Dysfunction in Sporadic Neurodegenerative Diseases

By  

Current Pharmaceutical Design, Vol. 17, Iss. 31, 2011-10 ,pp. : 3356-3373

Bentham Science Publishers

Access to resources Recommend Favorite

Expression Profiling of the Ephrin (EFN) and Eph Receptor (EPH) Family of Genes in Atherosclerosis-related Human Cells

By Sakamoto A   Sugamoto Y   Tokunaga Y   Yoshimuta T   Hayashi K   Konno T   Kawashiri MA   Takeda Y   Yamagishi M  

The Journal of International Medical Research, Vol. 39, Iss. 2, 2011-03 ,pp. : 522-527

Field House Publishing

Access to resources Recommend Favorite

Mitochondrial genome sequencing in atherosclerosis: what's next?

By  

Current Pharmaceutical Design, Vol. 22, Iss. 3, 2016-01 ,pp. : 390-396

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondrial DNA Mutations in Cancer: A Review

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 15, 2008-10 ,pp. : 1351-1366

Bentham Science Publishers

Access to resources Recommend Favorite